SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-10.1
Date Filed: 2026-03-25
Accession Number: 0001213900-26-034072
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026034072/ea028322301ex10-1.htm

Chunk 2 of 68
Word Count: 1497
Character Count: 9873

Document Content:

Section 2.5. Reduction of Commitment; Prepayment of Loans 54 54 Section 2.6. Fees 57 Section 2.7. Term SOFR Rate Option; Benchmark Replacement 58 Section 2.8. Funding Losses 61 61 Section 2.9. Taxes 61 Section 2.10. Increased Costs and Reduced Return 65 65 Section 2.11. Changes in Law; Impracticability or Illegality 66 66 Section 2.12. Replacement of Lenders 67 67 Section 2.13. Incremental Facilities 68 ARTICLE III [INTENTIONALLY OMITTED] 69 69 ARTICLE IV APPLICATION OF PAYMENTS; DEFAULTING LENDERS 69 69 Section 4.1. Payments; Computations and Statements 69 69 Section 4.2. Sharing of Payments 70 70 Section 4.3. Apportionment of Payments 71 Section 4.4. Defaulting Lenders 72 72 ARTICLE V CONDITIONS TO LOANS 73 73 Section 5.1. Conditions Precedent to Effectiveness 73 Section 5.2. Conditions Precedent to All Loans 78 78 Section 5.3. Conditions Subsequent to Effecitveness 79 ARTICLE VI REPRESENTATIONS AND WARRANTIES 80 81 Section 6.1. Representations and Warranties 80 81

ARTICLE VII COVENANTS OF THE LOAN PARTIES
AND OTHER COLLATERAL MATTERS	89 90

Section 7.1.	Affirmative Covenants	89 90

Section 7.2.	Negative Covenants	100 98

Section 7.3.	Financial Covenants	106 105

ARTICLE VIII EVENTS OF DEFAULT	107 106

Section 8.1.	Events of Default	107 106

ARTICLE IX AGENTS	110 109

Section 9.1.	Appointment	110 109

Section 9.2.	Nature of Duties; Delegation	112 110

Section 9.3.	Rights, Exculpation, Etc.	112 110

Section 9.4.	Reliance	113 111

Section 9.5.	Indemnification	113 111

Section 9.6.	Agents Individually	114 111

Section 9.7.	Successor Agent	114 112

Section 9.8.	Collateral Matters	114 112

Section 9.9.	Agency for Perfection	117 114

Section 9.10.	No Reliance on any Agent’s Customer Identification
Program	117 114

Section 9.11.	No Third-Party Beneficiaries	118 115

Section 9.12.	No Fiduciary Relationship	118 115

Section 9.13.	Reports; Confidentiality; Disclaimers	118 115

Section 9.14.	Collateral Custodian	119 116

Section 9.15.	Collateral Agent May File Proofs of Claim	119 116

Section 9.16.	Erroneous Distribution.	119 116

ARTICLE X GUARANTY	120 117

Section 10.1.	Guaranty	120 117

Section 10.2.	Guaranty Absolute	120 117

Section 10.3.	Waiver	124 118

Section
10.4.	Continuing
Guaranty; Assignments	121 118

Section
10.5.	Subrogation	122 119

Section
10.6.	Contribution	122 119

ARTICLE XI
MISCELLANEOUS	123 120

Section
11.1.	Notices,
Etc.	123 120

Section
11.2.	Amendments,
Etc.	125 122

Section
Waiver; Remedies, Etc.	127 124

Section
11.4.	Expenses;
Taxes; Attorneys’ Fees	127 125

Section
11.5.	Right
of Set-off	128 126

Section
11.6.	Severability	129 126

Section
11.7.	Assignments
and Participations	129 126

Section
11.8.	Counterparts	133 130

Section
11.9.	Governing
Law	133 130

Section
11.10.	Consent
to Jurisdiction; Service of Process and Venue	133 131

Section
11.11.	Waiver
of Jury Trial, Etc.	135 132

Section
11.12.	Consent
by the Agents and Lenders	135 132

Section
Party Deemed Drafter	135 133

Section
11.14.	Reinstatement;
Certain Payments	135 133

Section
11.15.	Indemnification;
Limitation of Liability for Certain Damages	136 133

Section
11.16.	Records	137 134

Section
11.17.	Binding
Effect	137 134

Section
11.18.	Highest
Lawful Rate	137 135

Section
11.19.	Confidentiality	138 136

Section
11.20.	Public
Disclosure	139 136

Section
11.21.	Integration	139 136

Section
11.22.	USA
PATRIOT Act	139 137

Section
11.23.	Judgment
Currency	139 137

Section
11.24.	Waiver
of Immunity.	140 137

Section
11.25.	English
Language	140 137

SCHEDULE
AND EXHIBITS

Schedule 1.1(A)	Lenders and Lenders’ Commitments

Schedule 1.1(B)	Effective Date Payoff Debt

Schedule 6.1(e)	Capitalization; Subsidiaries

Schedule 6.1(f)	Litigation

Schedule 6.1(o)	Facilities; Real Property

Schedule 6.1(p)	Employee and Labor Matters

Schedule 6.1(q)	Environmental Matters

Schedule 6.1(r)	Insurance

Schedule 6.1(u)	Deposit, Securities and Commodities Accounts

Schedule 6.1(v)	Intellectual Property

Schedule 6.1(w)	Material Contracts

Schedule 6.1(bb)	Name; Jurisdiction of Organization; Organizational
ID Number; Chief Place of Business; Chief Executive Office; FEIN

Schedule 7.2(a)	Existing Liens

Schedule 7.2(b)	Existing Indebtedness

Schedule 7.2(e)	Existing Investments

Schedule 7.2(j)	Existing Transactions with Affiliates

Schedule 7.2(k)	Limitations on Dividends and Other Payment Restrictions

Exhibit A	Form of Joinder Agreement

Exhibit B	Form of Security Agreement

Exhibit C	Form of Information Certificate

Exhibit D	Form of Assignment and Acceptance

Exhibit E	Form of Notice of Borrowing

Exhibit F	Form of Term SOFR Rate Notice

Exhibit G	Form of Compliance Certificate

Exhibit H	Forms of U.S. Tax Compliance Certificate

TERM
LOAN CREDIT AGREEMENT

This
TERM LOAN CREDIT AGREEMENT, dated as of May 30, 2025, is by and among SYNERGY CHC CORP., a Nevada corporation (the “Borrower”),
each subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto (together with each other Person that
executes a joinder agreement and becomes a “Guarantor” hereunder, each, a “Guarantor” and, collectively,
the “Guarantors”), the lenders from time to time party hereto (each, a “Lender” and, collectively,
the “Lenders”), ACP AGENCY, LLC (“ACP”), as administrative agent for the Lenders (in such
capacity, together with its successors and assigns in such capacity, the “Administrative Agent”), and ACP, as collateral
agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”,
and, together with the Administrative Agent, each, an “Agent” and, collectively, the “Agents”).

The
Borrower has asked the Lenders to enter into this Agreement (i) to extend credit to the Borrower consisting of (a) a term loan in the
aggregate principal amount of $15,000,000, and (b) a delayed draw term loan in the aggregate principal amount of up to $2,500,000, and
(ii) which contemplates that, subject to the satisfaction of certain conditions, the Borrower may request, from time to time, incremental
term loans in an aggregate principal amount not to exceed $2,500,000 pursuant to an incremental facility, which may be provided subject
to the discretion of the Administrative Agent. The proceeds of the term loan shall be used to repay existing indebtedness of the Borrower,
for general corporate purposes of the Borrower and to pay the Transaction Costs and the proceeds of the delayed draw term loan will be
used to pay the outstanding obligations of the Borrower under each of the Atrium Settlement Agreement and the Vitabest Settlement Agreement.
The Agents and the Lenders are willing to enter into this Agreement and the Lenders are severally, and not jointly, willing to extend
such credit to the Borrower subject to the terms and conditions hereinafter set forth.

consideration of the premises and the covenants and agreements contained herein, the parties hereto agree as follows:

ARTICLE

DEFINITIONS;
CERTAIN TERMS

Section
1.1. Definitions. As used in this Agreement, the following terms shall have the respective meanings indicated below:

“ABL
Facility” means a revolving credit facility or other asset-based lending facility entered into by one or more of the Loan Parties,
provided that:

(a) the
terms, conditions, covenants and documentation of such ABL Facility (including, without limitation, an intercreditor agreement among
the administrative agent, the collateral agent, and the lenders under the ABL Facility and the Agents, and an amendment to this Agreement),
shall each be in form and substance satisfactory to the Agents in their reasonable discretion; and

(b) all
or a portion of the proceeds of such ABL Facility will be used to immediately prepay the Obligations under this Agreement in accordance
with the terms set forth in Section 2.5(c)(vii), and no ABL Facility shall be incurred unless and until such prepayment has been (or
concurrently will be) made.

“Account”
has the meaning specified therefor in the UCC.

“Account
Debtor” means, with respect to any Person, each debtor, customer or obligor in any way obligated on or in connection with any
Account of such Person.

“ACP”
has the meaning specified therefor in the preamble to this Agreement.

“Acquisition”
means the acquisition (whether by means of a merger, consolidation or otherwise) of all of the Equity Interests of any Person or all
or substantially all of the assets of any Person or any division or business line of any other Person.

“Action”
has the meaning specified therefor in Section 11.12.

“Administrative
Agent” has the meaning specified therefor in the preamble to this Agreement.

“Administrative
Agent’s Account” means an account at a bank designated by the Administrative Agent from time to time as the account into
which the Loan Parties shall make all payments to the Administrative Agent for the benefit of the Agents and the Lenders under this Agreement
and the other Loan Documents.

“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly through one or more intermediaries, controls, is controlled
by, or is under common control with, such Person. For purposes of this definition, “control” of a Person means the power,
directly or indirectly, either to (a) vote 10% or more of the Equity Interests having ordinary voting power for the election of members
of the Board of Directors of such Person or (b) direct or cause the direction of the management and policies of such Person whether by
contract or otherwise. Notwithstanding anything herein to the contrary, in no event shall any Agent or any Lender be considered an “Affiliate”
of any Loan Party.

“Agent”
and “Agents” have the respective meanings specified therefor in the preamble to this Agreement

“Agent
Advances” has the meaning specified therefor in Section 9.8(a).

“Aggregate
Payments” has meaning specified therefor in Section 10.6.